非洲的克拉里思胺耐药Helicobacter pylori:一个系统的审查和元分析
Komla Mawunyo Dossouvi1, Tchilabalo Bouyo2, Simon Sognonnou3
1Department of Microbiology, Global Health Research Institute, Lomé, Togo. dossouvikomlamawunyo@gmail.com.
Antimicrobial resistance and infection control
|April 12, 2025
概括
抗克拉里胺素的海利cobacter pylori (CRHp) 影响了非洲27%的菌株,其中A2143G和A2142G突变很常见. 为了准确的监测和治疗指导,需要标准化的检测方法.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 杆菌 (H. pylori) 感染在非洲很普遍,影响56.5%的成人和47.1%的儿童.
- 抗克拉里胺素的H. pylori菌株 (CRHp) 是一个全球性的健康问题.
- 这项研究是首次对非洲的CRHp进行系统性审查和元分析.
研究的目的:
- 为了确定非洲CRHp的流行率.
- 识别来自非洲的H. pylori菌株中常见的突变,使其具有克拉里思罗米辛耐药性.
- 审查26年来CRHp流行趋势.
主要方法:
- 按照PRISMA 2020指南进行系统审查和元分析.
- 在多个电子数据库中进行文献搜索,包括PubMed,Scopus和Google Scholar.
- 关键词包括"克拉里思罗米"",海利菌","非洲国家名称"和"23S rRNA中的突变".
主要成果:
- 分析了来自23个非洲国家的65项研究 (1997-2022年),涉及5313种H. pylori菌株.
- 在非洲,CRHp的综合流行率为27% (95%CI:22,33).
- A2143G和A2142G是与清红素耐药性相关的主要23SrRNA突变.
结论:
- 标准化微生物学方法对于在非洲准确监测H. pylori耐药性至关重要.
- 非洲CRHp的患病率与全球水平相当,需要进一步进行代表性研究.
- 在等待进一步的数据之前,H. pylori的治疗应遵守AHMSG第一个拉各斯的共识指南.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
273
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
273
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
69
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
69
Peptic Ulcer Disease IV: Management
51
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
51
Gastritis III: Clinical Manifestations and Management
101
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
101


